Value
4.7/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 6.1 |
| Fwd P/E | 2.5 |
| PEG | 4.9 |
| Analyst target | 4.0 |
- ▸Forward P/E: 46.5x
- ▸PEG: 1.61
BRZE · Why this verdict
Why Braze (BRZE) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.2/10
ConfidenceHIGH
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
Braze is a fast-growing software platform (26% revenue growth, 24% FCF margin) trading at 46.6x forward earnings near its 52-week high and above the analyst target, with heavy insider selling and an overbought chart limiting the case.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Braze is growing revenue 26% YoY and passes the Rule of 40 with a score of 50, ranking as an industry growth leader. Growth breakdown | Revenue growth stays above 20% YoY and Rule of 40 stays above 40 over 12 months. | →Stable |
| CounterOperating margin and net margin are scored 0.0 out of 10, so growth is not yet producing GAAP profit. | ||
Braze is free-cash-flow positive despite a GAAP loss, with a 24% FCF margin and a 3.8% FCF yield. Quality breakdown | FCF margin stays above 20% as revenue scales. | →Stable |
| CounterFree cash flow in software is often boosted by stock-based compensation and deferred revenue, so GAAP losses may be the better measure of real profitability. | ||
Price of $45.75 is above the analyst target of $41.36 (upside -9.6%) and only 0.4% below the 52-week high, so valuation looks stretched at 46.6x forward P/E. Analyst target | Analysts raise targets above $48 on continued growth. | →Stable |
| CounterWith 15.0% downside to the stop and risk-to-reward of -0.64, the stock has more room to fall than rise on the consensus view. | ||
Insiders sold $19.8M over 90 days (0.38% of market cap) across 20 sales with no buys, a BEARISH insider signal. Insider | Insider selling slows below 0.2% of market cap over the next two quarters. | →Stable |
| CounterSoftware executives often sell stock grants on a schedule, and institutions are accumulating shares. | ||
RSI is at 90 with falling OBV (volume distribution) and a flat or negative 200-day slope, which signals late-cycle distribution risk after the run to the 52-week high. Momentum breakdown | RSI cools below 70 without price falling through the $42.55 stop level. | ↓Deteriorating |
| CounterStrong trends can stay overbought for a long time, and the stock still sits above its 200-day average. | ||
Braze is growing revenue 26% YoY and passes the Rule of 40 with a score of 50, ranking as an industry growth leader.
→StableGrowth breakdown
- Expectation
- Revenue growth stays above 20% YoY and Rule of 40 stays above 40 over 12 months.
CounterOperating margin and net margin are scored 0.0 out of 10, so growth is not yet producing GAAP profit.
Braze is free-cash-flow positive despite a GAAP loss, with a 24% FCF margin and a 3.8% FCF yield.
→StableQuality breakdown
- Expectation
- FCF margin stays above 20% as revenue scales.
CounterFree cash flow in software is often boosted by stock-based compensation and deferred revenue, so GAAP losses may be the better measure of real profitability.
Price of $45.75 is above the analyst target of $41.36 (upside -9.6%) and only 0.4% below the 52-week high, so valuation looks stretched at 46.6x forward P/E.
→StableAnalyst target
- Expectation
- Analysts raise targets above $48 on continued growth.
CounterWith 15.0% downside to the stop and risk-to-reward of -0.64, the stock has more room to fall than rise on the consensus view.
Insiders sold $19.8M over 90 days (0.38% of market cap) across 20 sales with no buys, a BEARISH insider signal.
→StableInsider
- Expectation
- Insider selling slows below 0.2% of market cap over the next two quarters.
CounterSoftware executives often sell stock grants on a schedule, and institutions are accumulating shares.
RSI is at 90 with falling OBV (volume distribution) and a flat or negative 200-day slope, which signals late-cycle distribution risk after the run to the 52-week high.
↓DeterioratingMomentum breakdown
- Expectation
- RSI cools below 70 without price falling through the $42.55 stop level.
CounterStrong trends can stay overbought for a long time, and the stock still sits above its 200-day average.
Per-dimension breakdown
Quality
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 9.3 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 4.8 |
| FCF quality | 8.2 |
| Moat | 7.2 |
| Rule of 40 | 8.2 |
| Piotroski F | 6.7 |
- ▸FCF-positive despite GAAP loss (FCF margin 24%, FCF yield 3.8%)
- ▸Rule of 40: 50 (pass)
Growth
9.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 9.0 |
- ▸Strong growth: 26% YoY
Momentum
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.3 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 94)
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 5.6 |
| erm sentiment | 0.0 |
- ▸Estimates falling as sentiment proxy (-20.1%)
Insider
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸Notable insider selling — $19,780,550 (0.381% of mkt cap)
- ▸Institutions accumulating
Peer rank
4.6/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.1 |
| quality rank | 1.1 |
| growth rank | 8.2 |
- ▸Industry growth leader
Technical
4.3/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 2.8 |
| support resistance | 0.1 |
| 52w position | 9.9 |
Risk (lower is worse)
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.9 |
| days to cover | 6.4 |
| volatility | 3.2 |
| put call | 4.5 |
| implied vol | 4.8 |
| max pain risk | 3.0 |
| beta | 8.4 |
| debt equity | 9.4 |
- ▸Above max pain $8
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
1.9/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 1.0 |
| earnings history | 1.1 |
| earnings timing | 5.0 |
| surprise avg | 0.3 |
- ▸Estimates down -20.1% (30d)
- ▸Earnings concerns: 1B/2M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (5)
- MOMENTUM:4.7>=4.5
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:35d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-0.7=NEGATIVE
Warning (3)
- MOMENTUM:4.7<5.5 (soft — BUY_NOW allowed but watch)
- INSIDER:0.38%=MODERATE
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.65
Upside
-9.7%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 3.9 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 9.0) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.7=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.65 — supplementary context, not the trigger for this path.
The strongest dimensions are Growth at 9.0, Risk (lower is worse) at 5.7, and Insider at 5.5; the weakest are Catalyst at 1.9, Sentiment at 3.8, and Technical at 4.3. The V9 engine flagged 1 failed gate with 3 warnings, producing an asymmetric reward-to-risk of -0.65 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Revenue Growth Rule Of 40
Trip ifRevenue growth falls below 18% YoY for 2 consecutive quarters.
- P2Fcf Positive Despite Gaap Loss
Trip ifFCF margin falls below 15% from the current 24%.
- P3Price Above Analyst Target
Trip ifShare price falls below $42.55, the stop level, from the current $45.75.
- P4Heavy Insider Selling
Trip ifInsider selling exceeds 1% of market cap over 90 days from the current 0.38%.
- P5Overbought Late Cycle Momentum
Trip ifRSI stays above 80 while OBV keeps falling for 4 more weeks.